Download presentation
Presentation is loading. Please wait.
Published byEthan Dean Modified over 9 years ago
1
Indication: Suspected Heart Failure With abnormal ECG or Intermediate BNP (100-400) BNP: Asymptomatic Murmur Asymptomatic Cardiomegaly On CXR Direct Access Echo RSCH
2
Footnote: Please do not use open access Echo but refer directly to consultant for: 1.Pts with symptoms and signs of CHF or very high BNP 2.Pts with symtomatic heart murmurs 3.Known heart failure with previous echo 4.Other cardiac problems Direct Access Echo RSCH
3
Drug therapy in CHF Diuretics ACE inhibitors B - blockers Spironolactone (Class III & IV patients) Angiotensin II receptor blockers (Alternative to ACE I) Hydralazine & ISDN (ACE I/ARB intolerance or in renal failure or in Afro- Carribeans as in the AHeFT trial) Digoxin if still symptomatic or in AF
4
Dose of ACE Inhibitors in CHF Enalapril2.5 mg od10-20 mg bd Lisinopril2.5 mg od20-40 mg od Perindopril2 mg od4 mg od Ramipril1.25-2.5 mg od10 mg od Initial Dose*Optimal Dose * If there are signs of dehydration, stop diuretics for 24 hrs before initial dose of ACE inhibitor
5
Summary of Drug Treatment of CHF CHF Confirmed ACE Inhibitors (or ARBs) Oedema Diuretics + Consider Spironolactone in Class III/IV pts No congestion Beta-blockers AF Digoxin + Warfarin Angina ISMN / Amlodipine
6
Conclusions BNP will help exclude heart failure ECG also useful in excluding CHF - can use this for triage Intermediate BNP levels can be found in CHF/IHD/ACS, treated CHF with non- cardiac cause of dyspnoea or non-CHF with non-cardiac cause of dyspnoea including PE and pneumonia Echocardiography for definitive diagnosis BNP and open access echocardiography now available for primary care in Guildford
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.